| Patent | Date |
|---|
Depletion Regimes For Engineered T-cell Or Nk-cell Therapy
App 20220288118 - Gibbs; Craig ; et al. | 2022-09-15 |
Methods For Achieving Therapeutically Effective Doses Of Anti-cd47 Agents
App 20220289845 - Willingham; Stephen ; et al. | 2022-09-15 |
Methods For Achieving Therapeutically Effective Doses Of Anti-cd47 Agents
App 20220251199 - Willingham; Stephen ; et al. | 2022-08-11 |
Multispecific Agents For Treatment Of Cancer
App 20220185905 - McCamish; Mark ; et al. | 2022-06-16 |
Treatment Of Cutaneous T Cell Lymphoma With Targeting Of Cd47 Pathway
App 20220119523 - Weissman; Irving L. ; et al. | 2022-04-21 |
Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr
App 20220033506 - Weissman; Irving L. ; et al. | 2022-02-03 |
Genetically Modified Hspcs Resistant To Ablation Regime
App 20220023348 - Gibbs; Craig ; et al. | 2022-01-27 |
Dosing Parameters for CD47 Targeting Therapies to Hematologic Malignancies
App 20210401979 - Majeti; Ravindra ; et al. | 2021-12-30 |
Methods For Achieving Therapeutically Effective Doses Of Anti-cd47 Agents
App 20210380689 - Willingham; Stephen ; et al. | 2021-12-09 |
Use of anti-CD47 agents to enhance immunization
Grant 11,154,600 - Tseng , et al. October 26, 2 | 2021-10-26 |
Dosing parameters for CD47 targeting therapies to hematologic malignancies
Grant 11,141,480 - Majeti , et al. October 12, 2 | 2021-10-12 |
Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody
Grant 11,136,391 - Willingham , et al. October 5, 2 | 2021-10-05 |
Treatment of cancer with dual targeting of CD47 and EGFR
Grant 11,130,813 - Weissman , et al. September 28, 2 | 2021-09-28 |
Compositions for achieving therapeutically effective doses of anti-CD47 agents
Grant 11,104,731 - Willingham , et al. August 31, 2 | 2021-08-31 |
Treatment Of Cancer With Combinations Of Immunoregulatory Agents
App 20210230276 - Willingham; Stephen ; et al. | 2021-07-29 |
Anti-sirp-alpha Antibodies And Related Methods
App 20210171654 - Liu; Jie ; et al. | 2021-06-10 |
Anti-SIRP-.alpha. antibodies and related methods
Grant 10,961,318 - Liu , et al. March 30, 2 | 2021-03-30 |
Methods For Achieving Therapeutically Effective Doses Of Anti-cd47 Agents
App 20210079093 - Willingham; Stephen ; et al. | 2021-03-18 |
Treatment Of Ovarian Cancer With Anti-cd47 And Anti-pd-l1
App 20210047416 - Takimoto; Chris Hidemi Mizufune ; et al. | 2021-02-18 |
Use Of Tlr Agonist And Anti-cd47 Agent To Enhance Phagocytosis Of Cancer Cells
App 20210038643 - Weissman; Irving L. ; et al. | 2021-02-11 |
Regimes For Co-administration Of Immunotherapeutic Agents Against C-kit And Cd47
App 20200369767 - Gibbs; Craig ; et al. | 2020-11-26 |
Macrophages eat cancer cells using their own calreticulin as a guide
Grant 10,780,117 - Weissman , et al. Sept | 2020-09-22 |
Anti SIRP-.alpha. antibodies and bi-specific macrophage enhancing antibodies
Grant 10,781,256 - Weiskopf , et al. Sept | 2020-09-22 |
Anti-CD47 Agent-Based Ovarian Cancer Therapy
App 20200283520 - Takimoto; Chris Hidemi Mizufune ; et al. | 2020-09-10 |
Disrupting FC Receptor Engagement on Macrophages Enhances Efficacy of Anti-SIRPalpha Antibody Therapy
App 20200262918 - Liu; Jie ; et al. | 2020-08-20 |
Dosing Parameters for CD47 Targeting Therapies to Hematologic Malignancies
App 20200147212 - Majeti; Ravindra ; et al. | 2020-05-14 |
SIRP-.alpha. agonist antibody
Grant 10,618,976 - Weissman , et al. | 2020-04-14 |
Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRP.alpha. antibody therapy
Grant 10,611,842 - Liu , et al. | 2020-04-07 |
Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr
App 20190322751 - Weissman; Irving L. ; et al. | 2019-10-24 |
Anti-CD47 Agent-Based Treatment of CD20-Positive Cancer
App 20190248915 - Chao; Mark Ping ; et al. | 2019-08-15 |
Methods For Achieving Therapeutically Effective Doses Of Anti-cd47 Agents
App 20190218289 - Willingham; Stephen ; et al. | 2019-07-18 |
Treatment of cancer with dual targeting of CD47 and EGFR
Grant 10,344,094 - Weissman , et al. July 9, 2 | 2019-07-09 |
Methods for achieving therapeutically effective doses of anti-CD47 agents
Grant 10,301,387 - Willingham , et al. | 2019-05-28 |
Anti-SIRP-Alpha Antibodies and Related Methods
App 20190119396 - Liu; Jie ; et al. | 2019-04-25 |
Methods For Determining And Achieving Therapeutically Effective Doses Of Anti-cd47 Agents In Treatment Of Cancer
App 20190106491 - Weissman; Irving L. ; et al. | 2019-04-11 |
Use Of Anti-cd47 Agents To Enhance Immunization
App 20180353582 - Tseng; Diane ; et al. | 2018-12-13 |
Anti SIRP-alpha Antibodies and Bi-specific Macrophage Enhancing Antibodies
App 20180319883 - Weiskopf; Kipp Andrew ; et al. | 2018-11-08 |
Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies
Grant 10,081,680 - Weiskopf , et al. September 25, 2 | 2018-09-25 |
Use of anti-CD47 agents to enhance immunization
Grant 10,064,925 - Tseng , et al. September 4, 2 | 2018-09-04 |
Sirp-alpha Agonist Antibody
App 20180171030 - Weissman; Irving L. ; et al. | 2018-06-21 |
Disrupting FC Receptor Engagement on Macrophages Enhances Efficacy of Anti-SIRPalpha Antibody Therapy
App 20180037652 - Liu; Jie ; et al. | 2018-02-08 |
Macrophages Eat Cancer Cells Using Their Own Calreticulin As A Guide
App 20180000865 - WEISSMAN; Irving L. ; et al. | 2018-01-04 |
Treatment Of Cancer With Combinations Of Immunoregulatory Agents
App 20170210803 - Willingham; Stephen ; et al. | 2017-07-27 |
Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr
App 20170166645 - Weissman; Irving L. ; et al. | 2017-06-15 |
Methods For Achieving Therapeutically Effective Doses Of Anti-cd47 Agents
App 20170145096 - Willingham; Stephen ; et al. | 2017-05-25 |
Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancer
Grant 9,623,079 - Willingham , et al. April 18, 2 | 2017-04-18 |
Anti SIRP-alpha Antibodies and Bi-specific Macrophage Enhancing Antibodies
App 20170073414 - Weiskopf; Kipp Andrew ; et al. | 2017-03-16 |
Use of Anti-CD47 Agents to Enhance Immunization
App 20160144009 - Tseng; Diane ; et al. | 2016-05-26 |
Methods for Achieving Therapeutically Effective Doses of anti-CD47 Agents
App 20160008429 - Willingham; Stephen ; et al. | 2016-01-14 |
| 